CompuGroup Medical SE & Co. KGaA (COP) — Net Asset Quality Index
CompuGroup Medical SE & Co. KGaA (COP) has a Net Asset Quality Index of 32.3% as of March 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €2.02 Billion minus total liabilities of €1.37 Billion yields net assets of €652.09 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check how resilient are CompuGroup Medical SE & Co. KGaA's assets to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
CompuGroup Medical SE & Co. KGaA Net Asset Quality Index Over Time (2004–2024)
This chart shows how CompuGroup Medical SE & Co. KGaA's Net Asset Quality Index has evolved across 21 annual periods from 2004 to 2024. As of March 2025, the index stands at 32.3%, representing net assets of €652.09 Million against total assets of €2.02 Billion EUR. See COP current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for CompuGroup Medical SE & Co. KGaA (2004–2024)
The table below presents the year-by-year Net Asset Quality Index for CompuGroup Medical SE & Co. KGaA from 2004 to 2024, covering 21 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see COP market cap.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 33.0% | €648.31 Million | €1.97 Billion | €1.32 Billion | ▼ -2.2 pp |
| 2023 | 35.2% | €669.27 Million | €1.90 Billion | €1.23 Billion | ▲ +0.6 pp |
| 2022 | 34.7% | €673.82 Million | €1.94 Billion | €1.27 Billion | ▲ +0.5 pp |
| 2021 | 34.2% | €612.28 Million | €1.79 Billion | €1.18 Billion | ▼ -6.6 pp |
| 2020 | 40.8% | €638.94 Million | €1.57 Billion | €926.84 Million | ▲ +16.4 pp |
| 2019 | 24.4% | €259.92 Million | €1.07 Billion | €805.95 Million | ▼ -7.8 pp |
| 2018 | 32.2% | €273.00 Million | €848.31 Million | €575.31 Million | ▲ +3.6 pp |
| 2017 | 28.6% | €236.06 Million | €825.01 Million | €588.95 Million | ▲ +1.5 pp |
| 2016 | 27.1% | €218.65 Million | €807.90 Million | €589.25 Million | ▲ +2.7 pp |
| 2015 | 24.3% | €192.61 Million | €791.68 Million | €599.07 Million | ▲ +0.5 pp |
| 2014 | 23.8% | €175.63 Million | €737.55 Million | €561.92 Million | ▼ -4.0 pp |
| 2013 | 27.8% | €192.64 Million | €692.08 Million | €499.45 Million | ▲ +0.3 pp |
| 2012 | 27.5% | €179.41 Million | €651.28 Million | €471.88 Million | ▲ +1.3 pp |
| 2011 | 26.3% | €168.20 Million | €640.71 Million | €472.51 Million | ▼ -6.6 pp |
| 2010 | 32.8% | €182.73 Million | €556.40 Million | €373.67 Million | ▼ -8.3 pp |
| 2009 | 41.1% | €185.83 Million | €451.78 Million | €265.95 Million | ▼ -2.7 pp |
| 2008 | 43.8% | €182.82 Million | €417.33 Million | €234.50 Million | ▼ -27.1 pp |
| 2007 | 70.9% | €198.02 Million | €279.26 Million | €81.24 Million | ▲ +46.2 pp |
| 2006 | 24.7% | €54.37 Million | €220.12 Million | €165.74 Million | ▼ -7.3 pp |
| 2005 | 32.0% | €44.98 Million | €140.77 Million | €95.79 Million | ▲ +11.0 pp |
| 2004 | 21.0% | €28.87 Million | €137.60 Million | €108.73 Million | — |